Radiology Business May 29, 2024
It’s a question on many radiologists’ minds: How will Medicare pay for artificial intelligence? Three health policy experts attempted to take a stab at finding an answer in a new viewpoint published Tuesday in JAMA Internal Medicine [1].
The U.S. Food and Drug Administration has now approved nearly 900 AI-enabled products, with the vast majority in radiology. Yet, the Centers for Medicare & Medicaid Services has only assigned payment for about 10 of these applications, limiting access for patients.
“The existing fee-for-service payment system is not well suited for these services, and payers must balance a desire for innovation and diffusion of high-value AI-enabled clinical services with a concern about their association with spending and potential overuse,” Anna Zink, PhD,...
Today's Sponsors
Today's Sponsor